2023; 22(2): fo-shou-san ameliorates chronic cerebral hypoperfusion-induced impairment in mice by regulating nrf2/ho-1 pathway

HIGHLIGHTS

  • who: Fo-Shou-Sanu037e vascular dementiau037e cognitive et al. from the Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China have published the paper: 2023u037e 22(2): Fo-Shou-San Ameliorates Chronic Cerebral Hypoperfusion-Induced Impairment in Mice by Regulating NRF2/HO-1 Pathway, in the Journal: (JOURNAL)
  • what: The authors propose that FSS could inhibit CCH-caused ferroptosis by regulating NRF2/HO-1 pathway. The data used and analyzed in the study are available from the corresponding author upon reasonable request.
  • how: Nimodipine (N837938 Mack2 lin China) a dihydropyridine Ca2 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?